Phosphatidylcholine membrane (PC membrane)

Phosphatidylcholine (PC) membranes are the primary structural components of eukaryotic cell bilayers, consisting of a glycerol backbone esterified to two fatty acids and a phosphocholine headgroup. These membranes are essential for maintaining cellular integrity, regulating the permeability of ions and small molecules, and providing a matrix for the function of membrane-bound proteins (PubChem CID 453). Beyond their structural role, PC membranes serve as a reservoir for secondary messengers in signal transduction and are vital components of biological fluids such as lung surfactant and bile (StatPearls: Lung Surfactant). In clinical pathology, a deficiency or alteration in PC membrane composition is strongly linked to ulcerative colitis, where the protective mucus barrier is compromised, and to non-alcoholic fatty liver disease (NAFLD), where PC is required for hepatic lipid export (PubMed: 21114793, PubMed: 22503486). Therapeutic strategies include lipid-replacement therapy to restore membrane function in chronic inflammatory states and the use of exogenous PC-based surfactants for neonatal respiratory distress. Additionally, certain pharmacological agents like miltefosine interact with PC metabolism or membrane structure to exert antiprotozoal effects, highlighting the membrane's role as both a protective barrier and a drug target (PubMed: 25118115).

Other names

Lecithin membranePhosphatidylcholine lipid bilayer1,2-diacyl-sn-glycero-3-phosphocholine membranePC bilayer

Drugs targeting phosphatidylcholine membranes typically act through membrane stabilization, lipid replacement to restore barrier function, or the exogenous supplementation of surfactants to reduce surface tension. In antimicrobial contexts, certain agents may disrupt the membrane potential or physical integrity of the bilayer to induce cell death.